申请人:Janssen Pharmaceutica N.V.
公开号:US05043327A1
公开(公告)日:1991-08-27
The present invention relates to novel positive inotropic and lusitropic 3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one derivatives having positive inotropic and lusitropic properties which are useful in the treatment of warm-blooded animals suffering from Congestive Heart Failure. Pharmaceutical compositions containing said compounds as an active ingredient. Methods of preparing said compounds and pharmaceutical compositions.
本发明涉及具有正肌力和正舒张作用的新型3,5-二氢咪唑并[2,1-b]喹唑啉-2(1H)-酮衍生物,其在治疗患有充血性心力衰竭的温血动物中具有积极作用。含有上述化合物作为活性成分的药物组合物。制备上述化合物和药物组合物的方法。